Skip Navigation
Skip to contents

J Clin Neurol.  2016 Jan;12(1):14-20. 10.3988/jcn.2016.12.1.14.

Clinical Trials of Adult Stem Cell Therapy in Patients with Ischemic Stroke

Affiliations
  • 1Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. ohyoung.bang@samsung.com
  • 2Translational and Stem Cell Research Laboratory on Stroke, Samsung Medical Center, Seoul, Korea.

Abstract

Stem cell therapy is considered a potential regenerative strategy for patients with neurologic deficits. Studies involving animal models of ischemic stroke have shown that stem cells transplanted into the brain can lead to functional improvement. With current advances in the understanding regarding the effects of introducing stem cells and their mechanisms of action, several clinical trials of stem cell therapy have been conducted in patients with stroke since 2005, including studies using mesenchymal stem cells, bone marrow mononuclear cells, and neural stem/progenitor cells. In addition, several clinical trials of the use of adult stem cells to treat ischemic stroke are ongoing. This review presents the status of our understanding of adult stem cells and results from clinical trials, and introduces ongoing clinical studies of adult stem cell therapy in the field of stroke.

Keyword

stroke; clinical trials; stem cells

MeSH Terms

Adult Stem Cells*
Adult*
Bone Marrow
Brain
Humans
Mesenchymal Stromal Cells
Models, Animal
Neurologic Manifestations
Stem Cells
Stroke*
Full Text Links
  • JCN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr